D.E. Shaw & Co’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $54.9K | Sell |
|
|||||
|
2022
Q3 | $770K | Sell |
|
|||||
|
2022
Q2 | $1.62M | Sell |
|
|||||
|
2022
Q1 | $2.79M | Buy |
|
|||||
|
2021
Q4 | $150K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $286K | Sell |
|
|||||
|
2020
Q3 | $785K | Sell |
|
|||||
|
2020
Q2 | $2.09M | Buy |
|
|||||
|
2020
Q1 | $513K | Buy |
|
|||||
|
2019
Q4 | $827K | Buy |
|
|||||
|
2019
Q3 | $148K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $489K | Buy |
|
|||||
|
2014
Q4 | $375K | Buy |
|
|||||
|
2014
Q3 | $196K | Buy |
|